Partial horizontal laryngectomy and epiglottiplasty

Abstract

In order to evaluate the availability of the lateral horizontal laryngectomy and anaplasty of epiglottis to treat some patients with specific supraglottic carcinomas and hypopharyngeal carcinomas, 17 cases of laryngeal and hypopharyngeal carcinomas were retrospectively analyzed, whose tumors were located at the lateral margin of epiglottis, aryepiglottic fold, medial wall of piriform fossa and were treated by the lateral horizontal laryngectomy and anaplasty of epiglottis. The results showed that all cases took food by mouth in postoperative 9–14 days and subjected to decannulation in postoperative 9–15 days. Three cases had postoperative hoarse voice. The free-disease survival rate of 3 years was 71.4% in 14 cases followed up after the first surgical therapy, and the overall free-disease survival rate of 3 years was 85.7% after the second surgical therapy. It was concluded that the manipulations of the lateral horizontal laryngectomy and epiglottiplasty were simple. It could alleviate the postoperative symptoms of aspiration and bucking remarkably and shorten their postoperative recovery time, yet does not lower the survival rate of patients if laryngocarcinoma or hypopharyngeal carcinoma cases were properly selected.

Keywords

laryngocarcinoma / hypopharyngeal carcinoma / partial laryngectomy / plastic operation

References

[1] SessionsD G, LenoxJ, SpectorG J, et al.. Supraglottic laryngeal cancer: Analysis of treatment results. Laryngoscope, 2005, 115(8): 1402-1410

[2] Har-ElG, PanielloR C, AbemayorE, et al.. Partial laryngectomy with imbrication laryngoplasty for glottic carcinoma. Arch Otolaryngol Head Neck Surg, 2003, 129(1): 66-71

[3] SamirN. The use of intensity-modulated radiation therapy in the treatment of otopharyngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg, 2005, 13(4): 226-226

[4] VokesE E, StensonK, RosenF R, et al.. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol, 2003, 21(2): 320-326

[5] StrongM S, JakoG J. Laser surgery in the larynx. Early clinical experience with continuous CO₂ laser. Ann Otol Rhinol Laryngol, 1972, 81: 791-798

[6] SpaffordM F, KoeppeJ, PanZ, et al.. Correlation of tumor marker P53, bcl-2, CD34, CD44H, CD44V6 and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolarygol Head Neck Surg, 1996, 122: 627-630

[7] DelaereP R, Vander PoortenV, VancloosterC, et al.. Results of larynx preservation surgery for advanced laryngeal cancer through tracheal autotransplantation. Arch Otolaryngol Head Neck Surg, 2000, 126(10): 1207-1215

[8] MyersE N, AlviA. Management of carcinoma of the supraglottic larynx: Evolution, current concepts, and future trends. Laryngoscope, 1996, 106(5): 559-567